PRND and triple-negative breast carcinoma: To confirm the previous findings, we detected Doppel concentration in the 1st validation set where we used archived sera of 76 OC patients with stage and histopathology information, 10 triple negative breast cancer (TNBC) patients, and 18 healthy females using ELISA.